Furthermore, tumor cell proliferation was suppressed by combination treatment, as indicated by the downregulation of Ki67, a proliferating cell-associated nuclear antigen that is directly correlated with gastric cancer progression [27, 28]. The gene discussed is MKI67; the disease is gastric cancer.